CA AB 54
introducedAccess to Safe Abortion Care Act.
California · 2025-2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did CA AB 54 pass?
Not yet. CA AB 54 has been introduced but has not advanced to a vote. Latest recorded action (2026-08-30): Ordered to inactive file at the request of Senator McNerney.
What is CA AB 54 about?
Existing law sets forth provisions, under the California Constitution, regarding the fundamental right to choose to have an abortion. Existing law, the Reproductive Privacy Act, prohibits the state from denying or interfering with a pregnant person's right to choose or obtain an abortion prior to viability of the fetus, or when the abortion is necessary to protect the life or health of the pregnant person. This bill, the Access to Safe Abortion Care Act, would make legislative findings about medication abortion, with a focus on use of the drugs mifepristone and misoprostol. Under the bill, the Legislature would reaffirm that it has been, and would continue to be, lawful to cause the delivery of, or mail, ship, take, receive, or otherwise transport, any drug, medicine, or instrument that can be designed or adapted to produce an abortion that is lawful in the State of California. The bill would set forth provisions regarding the lack of civil or criminal liability, or professional disciplinary action, for accessing or administering brand name or generic mifepristone or any drug used for medication abortion that is lawful under the laws of the state, on or after January 1, 2020, with this provision applied retroactively, as specified. The bill would make its provisions severable.
Who sponsors CA AB 54?
Krell is the primary sponsor of CA AB 54, joined by 14 cosponsors.
Description
Existing law sets forth provisions, under the California Constitution, regarding the fundamental right to choose to have an abortion. Existing law, the Reproductive Privacy Act, prohibits the state from denying or interfering with a pregnant person's right to choose or obtain an abortion prior to viability of the fetus, or when the abortion is necessary to protect the life or health of the pregnant person. This bill, the Access to Safe Abortion Care Act, would make legislative findings about medication abortion, with a focus on use of the drugs mifepristone and misoprostol. Under the bill, the Legislature would reaffirm that it has been, and would continue to be, lawful to cause the delivery of, or mail, ship, take, receive, or otherwise transport, any drug, medicine, or instrument that can be designed or adapted to produce an abortion that is lawful in the State of California. The bill would set forth provisions regarding the lack of civil or criminal liability, or professional disciplinary action, for accessing or administering brand name or generic mifepristone or any drug used for medication abortion that is lawful under the laws of the state, on or after January 1, 2020, with this provision applied retroactively, as specified. The bill would make its provisions severable.
- Introduced
- 2025-03-17
- Latest action
- 2026-08-30 — Ordered to inactive file at the request of Senator McNerney.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Krellauthor
- Cabaldonprincipal coauthor
- Cervantesprincipal coauthor
- Pérezprincipal coauthor
- Weber Piersonprincipal coauthor
- Bontacoauthor
- Harabediancoauthor
- Kalracoauthor
- Nguyencoauthor
- Pellerincoauthor
- Ransomcoauthor
- Sharp-Collinscoauthor
- Stefanicoauthor
- Aguiar-Curryauthor
- Zburcoauthor
Committees
Not provided by source.
Action timeline
Newest first
2026-08-30
Ordered to inactive file at the request of Senator McNerney.
2026-08-25
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2026-08-24
From inactive file.
2026-08-24
Ordered to second reading.
reading-1,reading-2
2025-09-10
Ordered to inactive file at the request of Senator Umberg.
2025-08-20
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2025-08-19
From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
committee-passage,reading-1,reading-2
2025-07-16
From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (July 15). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2025-07-01
Read second time and amended. Re-referred to Com. on JUD.
amendment-passage,reading-1,reading-2,referral-committee
2025-06-30
From committee: Amend, and do pass as amended and re-refer to Com. on JUD. (Ayes 9. Noes 1.) (June 25).
amendment-introduction,amendment-passage,committee-passage,referral-committee
2025-06-11
In committee: Set, first hearing. Hearing canceled at the request of author.
2025-05-21
Referred to Coms. on HEALTH and JUD.
referral-committee
2025-05-13
In Senate. Read first time. To Com. on RLS. for assignment.
reading-1,referral-committee
2025-05-12
Read third time. Passed. Ordered to the Senate. (Ayes 61. Noes 10. Page 1517.)
passage,reading-1,reading-3
2025-05-08
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2025-05-07
From committee: Do pass. (Ayes 11. Noes 1.) (May 7).
committee-passage,committee-passage-favorable
2025-04-30
From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 1.) (April 29). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2025-04-30
Coauthors revised.
2025-04-09
From committee: Do pass and re-refer to Com. on JUD. (Ayes 12. Noes 0.) (April 8). Re-referred to Com. on JUD.
committee-passage,committee-passage-favorable,referral-committee
2025-04-09
Coauthors revised.
2025-03-18
Re-referred to Com. on HEALTH.
referral-committee
2025-03-17
Referred to Coms. on HEALTH and JUD.
referral-committee
2025-03-17
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2024-12-03
From printer. May be heard in committee January 2.
2024-12-02
Read first time. To print.
reading-1
Versions
Documents
- application/pdf
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
Votes
Do pass and be re-referred to the Committee on [Judiciary]
2025-04-08 · pass · 12-0
Member-level votes (15)
- Sharp-Collins: yes
- Krell: yes
- Mark González: yes
- Carrillo: yes
- Arambula: yes
- Patel: yes
- Schiavo: yes
- Stefani: yes
- Celeste Rodriguez: yes
- Aguiar-Curry: yes
- Addis: yes
- Bonta: yes
- Flora: other
- Sanchez: other
- Chen: other
Do pass and be re-referred to the Committee on [Appropriations]
2025-04-29 · pass · 8-1
Member-level votes (12)
- Papan: yes
- Zbur: yes
- Connolly: yes
- Harabedian: yes
- Stefani: yes
- Bryan: yes
- Kalra: yes
- Pacheco: yes
- Macedo: no
- Dixon: other
- Bauer-Kahan: other
- Sanchez: other
Do pass.
2025-05-07 · pass · 11-1
Member-level votes (15)
- Calderon: yes
- Elhawary: yes
- Arambula: yes
- Fong: yes
- Wicks: yes
- Mark González: yes
- Pacheco: yes
- Hart: yes
- Caloza: yes
- Pellerin: yes
- Solache: yes
- Ta: no
- Sanchez: other
- Tangipa: other
- Dixon: other
AB 54 Krell Assembly Third Reading
2025-05-12 · pass · 61-10
Member-level votes (79)
- Carrillo: yes
- Alanis: yes
- Hart: yes
- Michelle Rodriguez: yes
- Sharp-Collins: yes
- Addis: yes
- Ward: yes
- Wicks: yes
- Garcia: yes
- Arambula: yes
- Lowenthal: yes
- Pacheco: yes
- Wallis: yes
- Gabriel: yes
- Petrie-Norris: yes
- Bonta: yes
- Soria: yes
- Alvarez: yes
- Solache: yes
- Harabedian: yes
- Ahrens: yes
- Aguiar-Curry: yes
- Muratsuchi: yes
- Papan: yes
- Caloza: yes
- Pellerin: yes
- Calderon: yes
- Mark González: yes
- Valencia: yes
- Lee: yes
- Ramos: yes
- Irwin: yes
- Quirk-Silva: yes
- Rivas: yes
- Wilson: yes
- Fong: yes
- Schiavo: yes
- Rogers: yes
- Blanca Rubio: yes
- McKinnor: yes
- Haney: yes
- Ávila Farías: yes
- Bennett: yes
- Ortega: yes
- Connolly: yes
- Berman: yes
- Ransom: yes
- Bauer-Kahan: yes
- Krell: yes
- Bryan: yes
- Celeste Rodriguez: yes
- Nguyen: yes
- Zbur: yes
- Elhawary: yes
- Patel: yes
- Boerner: yes
- Bains: yes
- Gipson: yes
- Jackson: yes
- Kalra: yes
- Schultz: yes
- Ellis: no
- Gallagher: no
- Sanchez: no
- Macedo: no
- Patterson: no
- Castillo: no
- DeMaio: no
- Hadwick: no
- Ta: no
- Lackey: no
- Hoover: other
- Flora: other
- Tangipa: other
- Davies: other
- Jeff Gonzalez: other
- Stefani: other
- Chen: other
- Dixon: other
Do pass as amended, but first amend, and re-refer to the Committee on [Judiciary]
2025-06-25 · pass · 9-1
Member-level votes (11)
- Menjivar: yes
- Rubio: yes
- Richardson: yes
- Weber Pierson: yes
- Wiener: yes
- Gonzalez: yes
- Padilla: yes
- Limón: yes
- Durazo: yes
- Grove: no
- Valladares: other
Do pass, but first be re-referred to the Committee on [Appropriations]
2025-07-15 · pass · 11-0
Member-level votes (13)
- Caballero: yes
- Wahab: yes
- Ashby: yes
- Wiener: yes
- Laird: yes
- Umberg: yes
- Weber Pierson: yes
- Stern: yes
- Allen: yes
- Arreguín: yes
- Durazo: yes
- Valladares: other
- Niello: other
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-08-31T23:53:24.419297Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 54. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.